Welcome to our dedicated page for Seres Therapeutics SEC filings (Ticker: MCRB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Seres Therapeutics, Inc. filings document the disclosure record of a Nasdaq-listed biotechnology company focused on live biotherapeutic and microbiome-based therapeutic programs. Its Form 8-K reports furnish quarterly and annual financial results, operational updates, Regulation FD corporate presentations, and material-event disclosures involving pipeline priorities, clinical and regulatory matters, capital allocation, cost-reduction actions, and financing or partnership activity.
The company’s proxy materials cover annual meeting mechanics, stockholder voting, board governance, executive compensation, and equity-award information. SEC filings also identify Seres’ common stock registered under the Exchange Act and traded on the Nasdaq Global Select Market under the symbol MCRB.